Angiodynamics Inc (ANGO) 16.59 $ANGO Shares of ANGO Up

New Post Public Reply Private Reply Replies (0) Message Board

Jul 31, 2016 at 11:25 PM

Angiodynamics Inc (ANGO) 16.59 $ANGO

Shares of ANGO Up 46.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jul 29, 12:39PM CDT
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on March 7th, 2016 at $11.40. In approximately 5 months, Angiodynamics has returned 46.20% as of today's recent price of $16.66.
ANGO: 16.59 (+0.07)

AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer
GlobeNewswire - Mon Jul 25, 6:34AM CDT
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of Michael Greiner as the company's new Executive Vice President and Chief Financial Officer, effective August 16, 2016.
ANGO: 16.59 (+0.07)

InTouch Health Announces New CEO
BusinessWire - Tue Jul 19, 7:30AM CDT
InTouch Health, the leading telehealth network and managed service provider, has appointed Joseph M. DeVivo as its new Chief Executive Officer. Mr. DeVivo was most recently President, CEO and Director of AngioDynamics (NASDAQ: ANGO), a $360 million (in annual revenue) publicly traded global leader in peripheral vascular, vascular access and interventional oncology. He brings more than 25 years of healthcare industry and leadership experience ranging from entrepreneurial to multi-billion dollar organizations, including Global President of Smith & Nephew Orthopedics (NASDAQ: SNN), a $2 billion (in annual revenue) global operation.
SNN: 33.29 (+0.64), ANGO: 16.59 (+0.07)

AngioDynamics (ANGO) Tops Q4 Earnings, '17 View Positive
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 4:14PM CDT
Shares of AngioDynamics Inc. (ANGO) rallied almost 10%, after the company reported impressive fourth quarter fiscal 2016 results.
ABMD: 117.97 (+2.94), MASI: 52.97 (+0.39), MLAB: 115.63 (-3.92), ANGO: 16.59 (+0.07)

AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results
GlobeNewswire - Wed Jul 13, 5:00AM CDT
-- Q4 Net sales of $93.4 million, up 3% year-over-year
ANGO: 16.59 (+0.07)

Can AngioDynamics' (ANGO) Q4 Earnings Pull a Surprise?
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 9:25AM CDT
AngioDynamics Inc (ANGO) is set to report fourth-quarter fiscal 2016 results on Jul 13.
PMC: 26.56 (+0.25), LH: 139.56 (+1.05), ANGO: 16.59 (+0.07), COO: 182.47 (+1.53)

PAVmed Inc. (Nasdaq: PAVMU) to Ring The Nasdaq Stock Market Opening Bell
GlobeNewswire - Thu Apr 28, 11:09AM CDT
What:
PAVMU: 14.53 (+0.23), ANGO: 16.59 (+0.07), NDAQ: 70.76 (-0.11)

AngioDynamics Tops Q3 Earnings, Sales; FY16 View Pruned
Zacks Equity Research - Zacks Investment Research - Fri Apr 08, 9:00AM CDT
AngioDynamics Inc. (ANGO) reported adjusted earnings of 15 cents per share in the third quarter of fiscal 2016, which beat the Zacks Consensus Estimate by a couple cents.
LMAT: 17.20 (+0.61), AMAG: 26.53 (-0.06), ANGO: 16.59 (+0.07), OFIX: 47.40 (+0.13)

Natus Medical: A Strong Sell on Weak Q1 & Estimate Revision
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 12:00PM CDT
On Apr 7, Zacks Investment Research downgraded Natus Medical Inc (BABY) to a Zacks Rank #5 (Strong Sell).
BABY: 39.33 (-0.24), GMED: 22.95 (+0.47), ARAY: 5.48 (unch), ANGO: 16.59 (+0.07)

Mazor Robotics Receives 5 Orders in Q1, Shares Down
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 12:20PM CDT
Shares of Mazor Robotics Ltd. (MZOR) fell 4.1% to close at $11.60 on Apr 5, after the company announced the receipt of five orders for Renaissance system.
GMED: 22.95 (+0.47), MZOR: 22.66 (+0.53), ARAY: 5.48 (unch), ANGO: 16.59 (+0.07)

Downgrade Alert for Angiodynamics (ANGO)
Comtex SmarTrend(R) - Wed Apr 06, 3:16AM CDT
Angiodynamics (NASDAQ:ANGO) was downgraded from Buy to Hold at Canaccord Genuity today. The stock closed yesterday at $11.07 on volume of 222,000 shares, above average daily volume of 75,000. AngioDynamics, Inc. designs, develops, manufactures, and markets therapeutic and diagnostic devices. The Company's products enable interventional physicians to treat peripheral vascular disease and other non-coronary diseases. AngioDynamic's product lines consist of angiographic catheters, hemodialysis catheters, image guided vascular access products, and thrombolytic products.
ANGO: 16.59 (+0.07)

Can the Uptrend Continue for AngioDynamics (ANGO)?
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 8:49AM CDT
Investors certainly have to be happy with AngioDynamics, Inc. (ANGO) and its short term performance
ANGO: 16.59 (+0.07)

AngioDynamics Appoints James C. Clemmer as New President and Chief Executive Officer
GlobeNewswire - Mon Apr 04, 7:00AM CDT
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of James C. Clemmer as the company's new President and Chief Executive Officer, effective April 4, 2016.
ANGO: 16.59 (+0.07)

AngioDynamics to Report Fiscal 2016 Third Quarter Financial Results
GlobeNewswire - Tue Mar 29, 5:30AM CDT
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 third quarter ended February 29, 2016, on Thursday, April 7, 2016, after the close of the U.S. financial markets.
ANGO: 16.59 (+0.07)

Inogen (INGN) Q4 Earnings: A Surprise in the Cards?
Zacks Equity Research - Zacks Investment Research - Fri Mar 11, 9:50AM CST
Inogen Inc. (INGN) is scheduled to report fourth-quarter 2015 earnings on Mar 14.
EW: 114.52 (+1.53), INGN: 53.74 (+1.00), LMNX: 21.43 (-1.15), ANGO: 16.59 (+0.07)

AngioDynamics and Merz North America Establish Multi-Year Relationship to Market Asclera for Vein Patients
GlobeNewswire - Thu Mar 10, 5:30AM CST
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that they have signed an agreement with Merz North America, U.S. affiliate of the global Merz Pharma Group, to serve as the exclusive distributor of Asclera(R) (polidocanol) Injection within the vein market in the U.S.
ANGO: 16.59 (+0.07)

AngioDynamics to Present at the Barclays Global Healthcare Conference
GlobeNewswire - Mon Mar 07, 5:30AM CST
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo, President and Chief Executive Officer, is scheduled to participate in a Q&A session at the Barclays Global Healthcare Conference on Thursday, March 17, 2016, at 8:00 a.m. ET. The conference will be held at the Loews Miami Beach Hotel in Miami, FL.
ANGO: 16.59 (+0.07)

AngioDynamics: Health Canada Okays Celerity with Navigation
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 3:20PM CST
AngioDynamics (ANGO) recently announced that Health Canada has approved the company's Celerity PICC Tip Confirmation System with Navigation.
ABMD: 117.97 (+2.94), EXAC: 27.03 (+0.15), LMNX: 21.43 (-1.15), ANGO: 16.59 (+0.07)

Mauna Kea Technologies Announces the Appointment of Joseph DeVivo as a Non-Executive Director
PR Newswire - Mon Jan 11, 11:00AM CST
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced the appointment of Joseph M. DeVivo as a Director. Mr. DeVivo is the President and Chief Executive Officer of AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology.
ANGO: 16.59 (+0.07)

AngioDynamics Q2 Earnings In Line, Sales Top; '16 View Cut
Zacks Equity Research - Zacks Investment Research - Fri Jan 08, 8:20AM CST
AngioDynamics (ANGO) reported adjusted earnings of 14 cents per share in the second quarter of fiscal 2016, which were in line with the Zacks Consensus Estimate but down 17.6% on a year-over-year basis.
CAPR: 3.70 (-0.03), NXTM: 22.11 (-0.15), ABAX: 49.46 (-0.26), ANGO: 16.59 (+0.07)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OmniActive's Fenavari: A New Era in Women's Health

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Celebree Gains Franchise Momentum: A New Frontier

The Climb: Celebree Schools on the Rise Here's a nugget in the franchise world that's causing a stir: Celebree School is making moves up the Franchise Times Top 400. When we're talking about a hop, skip, and jump through 84 spots since 2023, you can't help but notice. It's the third year in a row they're climbing this ladder, and it's making ripples. Franchise Expansion...

Trial for Former OB/GYN Arthur Park Begins in Bakersfield

A Somber Day for Justice in Bakersfield There’s a buzz in the air, thick with anticipation and grief, as a trial seven years in the making kicks off in Bakersfield. It’s a significant affair, marking a turning point in a saga that’s shadowed the region with untold grief and unresolved accountability. We’re talking about the trial of Arthur Park, a former OB/GYN,...

Montessori and Tech: A New Era of Integration

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

New American Funding Expands in Carolinas with Mullinix Move

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Simple Home Upgrades That Boost Value Fast

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

Partner Valuation Advisors Bolsters Team with Eichman

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Skiptown Expands in Georgia Amid Growing Demand

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Veterans Transitioning to Real Estate with Scholarships

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Dr. Anderson’s Journey: Leadership with Faith and Service

A Life Shaped by Service Dr. Howard Anderson isn't just another name in a glossy award roster—he's a powerhouse of leadership, a chaplain of compassion, and a soldier in spirit. Honored as a Pinnacle Professional Member of The Inner Circle of Excellence, his recognition feels less like an accolade and more like a testament to a life committed to serving others. The...